Sign In

Philip Lee

CEO at GeneFab

Philip Lee is the Chief Executive Officer at GeneFab, a company focused on contract research, development, and manufacturing in the cell and gene therapy field. He assumed this role in August 2023 after resigning as the Chief Technology Officer at Senti Biosciences, where he was also a co-founder.123 Lee holds a Ph.D. in Bioengineering from the University of California, Berkeley, and has over 20 years of experience in the life sciences industry, particularly in technology innovation and entrepreneurship.34

Before joining GeneFab, Lee held various leadership positions, including Chief Operating Officer and Chief Technology Officer at Senti Biosciences, where he contributed to raising significant capital and leading technical operations.3 He was also the co-founder and CEO of CellASIC, where he pioneered microfluidic cell culture systems.4 His expertise spans synthetic biology, product development, business strategy, and team management.34

Highlights

Apr 29 · linkedin

We've been working on some exciting new #genetherapy technologies over the past year and can't wait to debut them at #ASGCT2024! Join us in Baltimore May 7-11 at Booth #1641 to discuss!

Feb 29 · linkedin

Excited to be a member of the Presenting Company class of the BioCentury-BayHelix East-West Biopharma Summit 2024: Singapore. For more information or to register and join us at the event, visit https://lnkd.in/gxK7X9Dz #BioCenturyEastWest poweredby.ingo.me

Related Questions

What are Philip Lee's key achievements at Senti Bio?
How did Philip Lee's background in bioengineering influence his career?
What are the main goals of GeneFab under Philip Lee's leadership?
How does GeneFab's technology platform differ from other CRDMOs?
What challenges did Philip Lee face when transitioning from Senti Bio to GeneFab?
Philip Lee
Philip Lee, photo 1
Philip Lee, photo 2
Add to my network

Location

United States